Medication info
Eglid Tablet (Glimepiride)

Eglid Tablet (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
White Life Science Co., Ltd.
Appearance
Green rectangular tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201309458 · Approved 2013.09.27 · Insurance code 625200200

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust individually for each patient. Swallow without chewing with at least 1/2 cup of water. This drug is administered orally once daily. Take this drug before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses greater than 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg per day is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this drug may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered when weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this drug There is no exact dose equivalence between this drug and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this drug, it is advisable to follow the method described under Initial dose. That is, initiate treatment at 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previous drug should be considered. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this drug and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this drug once daily with the first meal. Initiate insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose, if possible, every day. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this drug, addition of metformin may be considered. When this drug is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia when this drug is administered concomitantly with metformin, and the risk may increase. Appropriate precautions should be taken.

Ingredients

Manufacturer
White Life Science Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Abnormal blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used as an adjunct to diet and exercise to help control blood sugar levels in patients with type 2 diabetes. It can be used alone, but if sufficient effectiveness is not achieved with oral hypoglycemic agents, it can be combined with insulin. Additionally, if blood sugar control is difficult with sulfonylureas or monotherapy with metformin, it improves blood sugar management when administered in combination with metformin. This medication effectively helps patients control their blood sugar and plays an important role in diabetes treatment.

How to take

Adult dose

Adjust individually for each patient. Swallow without chewing with at least 1/2 cup of water. This drug is administered orally once daily. Take this drug before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses greater than 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg per day is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this drug may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered when weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this drug There is no exact dose equivalence between this drug and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this drug, it is advisable to follow the method described under Initial dose. That is, initiate treatment at 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previous drug should be considered. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this drug and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this drug once daily with the first meal. Initiate insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose, if possible, every day. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this drug, addition of metformin may be considered. When this drug is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia when this drug is administered concomitantly with metformin, and the risk may increase. Appropriate precautions should be taken.

Precautions

This medication is not for use in patients with insulin-dependent diabetes, diabetic ketoacidosis, or in a comatose state. Patients who have had allergic reactions to this medication or sulfonylureas or sulfanilamides should not be administered this medication. There is no experience using this medication in patients with severely impaired liver or kidney function; in such cases, switching to insulin therapy is recommended. This medication should not be administered to pregnant women or those who may become pregnant, or to breastfeeding women. Severe infections, pre- and post-surgery, and severe trauma patients may require insulin therapy; therefore, this medication should not be used. Caution should be exercised when gastrointestinal disturbances such as diarrhea or vomiting occur, as absorption of food may be inadequate, increasing the risk of hypoglycemia. This medication contains lactose, and patients with lactose intolerance or specific genetic disorders should not take it. In the first week of administration of this medication, there is a higher risk of hypoglycemia, so blood sugar levels must be monitored closely. Special caution is needed for elderly patients, those who are malnourished or skip meals, those with unbalanced exercise and carbohydrate intake, those with sudden changes in eating habits, frequent alcohol consumers, patients with weak liver or kidney function, patients with other endocrine disorders, and in cases of drug overdose. Additionally, when taking certain medications such as beta-blockers, hypoglycemic symptoms may not be easily noticeable. This medication has a blood sugar-lowering effect and may lead to hypoglycemia, with symptoms including headache, severe hunger, nausea, fatigue, anxiety, confusion, dizziness, drowsiness, and in severe cases, loss of consciousness. If hypoglycemia occurs, it is important to quickly consume sugar-containing foods. There can be rare occurrences of blurred vision, gastrointestinal disturbances, liver function abnormalities, decreased blood cell counts, and allergic reactions, so any abnormal symptoms should be reported to a doctor immediately. In particular, if severe allergic symptoms such as hives or difficulty breathing occur, the medication should be discontinued, and immediate medical attention should be sought. When taking this medication, it is important to take it regularly and maintain diet and exercise therapy. Patients should be well aware of hypoglycemic symptoms and treatments, and be prepared to quickly consume sugar in the event of hypoglycemia. Additionally, special situations such as stress, surgery, or infection may complicate blood sugar control, so consultation with a physician is necessary. When taking other medications, the effectiveness of this medication may be altered, so all medications being taken should be disclosed to the physician or pharmacist. In particular, medications that affect enzymes that break down this drug in the liver, or medications that raise or lower blood sugar levels may have interactions.

Side effects

  • Hypoglycemia
  • headache
  • severe hunger
  • nausea
  • vomiting
  • fatigue
  • sleep
  • sleep disorders
  • anxiety
  • aggression
Show 68 more
  • decreased concentration
  • decreased agility or activity
  • depression
  • confusion
  • speech abnormalities
  • aphasia
  • visual impairment
  • tremors
  • partial paralysis
  • sensory disturbances
  • dizziness
  • weakness
  • loss of self-control
  • temporary mental confusion
  • brain convulsions
  • drowsiness
  • loss of consciousness
  • coma
  • shallow breathing
  • bradycardia
  • sweating
  • cold and clammy skin
  • tachycardia
  • hypertension
  • palpitations
  • angina
  • deep vein thrombosis
  • blurred vision
  • fullness in the upper abdomen
  • pressure
  • abdominal pain
  • diarrhea
  • elevated liver enzymes
  • liver dysfunction
  • biliary secretion disorder
  • jaundice
  • hepatitis
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • erythrocytopenia
  • granulocytopenia
  • agranulocytosis
  • pancytopenia
  • itching
  • hives
  • rash
  • respiratory distress
  • hypotension
  • shock
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • allergic vasculitis
  • photosensitivity reactions of the skin
  • decreased serum sodium concentration
  • taste disturbances
  • hair loss
  • weight gain
  • dizziness
  • liver dysfunction
  • abdominal pain
  • arthralgia
  • dyspepsia
  • facial edema
  • erectile dysfunction
  • flushing
  • gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It should be stored at room temperature, between 1 and 30 degrees Celsius, for optimal safety.

Appearance and packaging

Appearance

Green rectangular tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.